The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
Open accessAbstract
Objectives The goal of this study was to assemble a profile and assess the significance of arrhythmias in a nontertiary-based hypertrophic cardiomyopathy (HCM) cohort.Background Hypertrophic cardiomyopathy is associated with arrhythmia-related consequences, particularly sudden death. Ventricular tachyarrhythmias on Holter electrocardiograms (ECG) have been reported as markers for sudden death in highly selected HCM populations.Methods We assessed the profile of ventricular and supraventricular ectopy and bradyarrhythmia on ambulatory 24-h Holter ECG and also related these findings to clinical outcome in 178 HCM patients.Results Of the 178 study patients, 157 (88%) had premature ventricular complexes (PVCs), including 21 (12%) with >/=500 PVCs, 74 (42%) had couplets, 67 (37%) had supraventricular tachycardia (SVT), and 56 (31%) had nonsustained ventricular tachycardia (NSVT). Mean number of PVCs was 330 +/- 763 (range 1 to 5,435) and increased with age (p < 0.01); NSVT was associated with greater left ventricular hypertrophy (p = 0.01) and severe symptoms (New York Heart Association functional classes III and IV) (p = 0.04); SVT occurred more commonly in patients with outflow obstruction (p = 0.02). Over a follow-up of 5.5 +/- 3.4 years, 11 (6%) patients died suddenly (annual mortality rate, 1.1%) including 5 patients with NSVT. For sudden death, NSVT on Holter ECG had negative and positive predictive values of 95% and 9%, and sensitivity and specificity of 45% and 69%, respectively.Conclusions In this nontertiary-based HCM cohort, ventricular and supraventricular tachyarrhythmias were particularly frequent and demonstrated a broad spectrum on ambulatory (Holter) ECG. Paradoxically, despite such a highly arrhythmogenic substrate, sudden death events proved to be relatively uncommon. Ventricular tachyarrhythmias had a low positive and relatively high negative predictive value for sudden death in this HCM population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Up to 30% of HCM patients present with NSVT episodes on Holter monitoring”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Adabag et al., 2005
The cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, NSVT is characterized by high negative (95%) but low positive predictive values”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Adabag et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,119
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citationHypertensive, Y., & Chin, K. (1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,757
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citationMagnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,050
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026
Self-citationSudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citation
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,671
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationO'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Chan, R. H., Maron, B. J., Olivotto, I., Pencina, M. J., Assenza, G. E., Haas, T., Lesser, J. R., Gruner, C., Crean, A. M., Rakowski, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007094 · Cited by 962
Self-citationOmmen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.071 · Cited by 662
Self-citation2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 641
Maron, M. S., Finley, J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., & Maron, B. J. (2008) · Circulation · doi:10.1161/circulationaha.108.781401 · Cited by 566
Self-citation2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 342
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000938 · Cited by 336
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 326
Self-citationSteinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
Varró, A., Tomek, J., Nagy, N., Virág, L., Passini, E., Rodríguez, B., & Baczkó, I. (2020) · Physiological Reviews · doi:10.1152/physrev.00024.2019 · Cited by 272
O’Mahony, C., Jichi, F., Ommen, S. R., Christiaans, I., Arbustini, E., Garcia-Pavia, P., Cecchi, F., Olivotto, I., Kitaoka, H., Gotsman, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030437 · Cited by 201
Gimeno, J. R., Tome, M., Lofiego, C., Hurtado, J., Pantazis, A. A., Mist, B., Lambiase, P. D., McKenna, W. J., & Elliot, P. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp327 · Cited by 209
Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M. (2010) · EP Europace · doi:10.1093/europace/eup431 · Cited by 176
Kuriachan, V. P., Sumner, G., & Mitchell, L. B. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.01.002 · Cited by 166
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy
Finocchiaro, G., Sheikh, N., Biagini, E., Papadakis, M., Maurizi, N., Sinagra, G., Pelliccia, A., Rapezzi, C., Sharma, S., & Olivotto, I. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.07.019 · Cited by 132
Kwon, D. H., Setser, R. M., Popović, Z., Thamilarasan, M., Sola, S., Schoenhagen, P., Garcia, M. J., Flamm, S. D., Lever, H. M., & Desai, M. Y. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9292-6 · Cited by 123
Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management
Baxi, A. J., Restrepo, C. S., Vargas, D., Marmol-Velez, A., Ocazionez, D., & Murillo, H. (2016) · Radiographics · doi:10.1148/rg.2016150137 · Cited by 123
Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy
Prondzynski, M., Lemoine, M. D., Zech, A. T. L., Horváth, A., Mauro, V. D., Koivumäki, J. T., Kresin, N., Busch, J., Krause, T., Krämer, E., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201911115 · Cited by 121
Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.01.001 · Cited by 138
Nonsustained Ventricular Tachycardia
Katritsis, D. G., Zaręba, W., & Camm, A. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.063 · Cited by 123
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 123
Bogle, C., Colan, S. D., Miyamoto, S. D., Choudhry, S., Hernandez, N. B., Brickler, M. M., Feingold, B., Lal, A. K., Lee, T. M., Canter, C. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001151 · Cited by 114
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 106
Wang, W., Lian, Z., Rowin, E. J., Maron, B. J., Maron, M. S., & Link, M. S. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004604 · Cited by 103
Self-citationFluechter, S., Kuschyk, J., Wolpert, C., Doesch, C., Veltmann, C., Haghi, D., Schoenberg, S. O., Sueselbeck, T., Germans, T., Streitner, F., et al. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-30 · Cited by 96
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.001 · Cited by 92
Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia
Wolf, C. M., Moskowitz, I. P. G., Arno, S., Branco, D. M., Semsarian, C., Bernstein, S., PETERSON, M. W., Maida, M., Morley, G. E., Fishman, G. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509145102 · Cited by 90
Cuoco, F. A., Spencer, W. H., Fernandes, V. L. C., Nielsen, C. D., Nagueh, S. F., Sturdivant, J. L., Leman, R. B., Wharton, J. M., & Gold, M. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.061 · Cited by 90
Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J., & Spirito, P. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01147.x · Cited by 89
Self-citationFounder mutations in hypertrophic cardiomyopathy patients in the Netherlands
Christiaans, I., Nannenberg, E. A., Dooijes, D., Jongbloed, R. J. E., Michels, M., Postema, P. G., Majoor‐Krakauer, D. F., van den Wijngaard, A., Mannens, M. M. A. M., van Tintelen, J. P., et al. (2010) · Netherlands Heart Journal · doi:10.1007/bf03091771 · Cited by 79
Coppini, R., Ferrantini, C., Mugelli, A., Poggesi, C., & Cerbai, E. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01391 · Cited by 78
Appelbaum, E. A., Maron, B. J., Adabağ, S., Hauser, T. H., Lesser, J. R., Haas, T. S., Riley, A. B., Harrigan, C. J., Delling, F. N., Udelson, J. E., et al. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.963819 · Cited by 74
Self-citationVentricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 87
Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Macintyre, C. J., & Lakdawala, N. K. (2016) · Circulation · doi:10.1161/circulationaha.115.015085 · Cited by 73
Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis
Liu, Q., Li, D., Berger, A. E., Johns, R. A., & Gao, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12289-4 · Cited by 66
Ismail, T. F., Prasad, S. K., & Pennell, D. J. (2011) · Heart · doi:10.1136/heartjnl-2011-300814 · Cited by 62
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management
Ali, A. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1556 · Cited by 62
Saumarez, R. C., Pytkowski, M., Sterlinski, M. M., Bourke, J. P., Clague, J. R., Cobbe, S. M., Connelly, D. T., GRIFFITH, M. J., McKeown, P., McLEOD, K. A., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn111 · Cited by 60
O’Mahony, C., Akhtar, M. M., Anastasiou, Z., Guttmann, O. P., Vriesendorp, P. A., Michels, M., Magrì, D., Autore, C., Fernández, A., Ochoa, J. P., et al. (2018) · Heart · doi:10.1136/heartjnl-2018-313700 · Cited by 59
Salvo, G. D., Pacileo, G., Limongelli, G., Baldini, L., Rea, A., Verrengia, M., D’Andrea, A., Russo, M. G., & Calabrò, R. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.02.013 · Cited by 61
Hartlage, G. R., Kim, J. H., Strickland, P. T., Cheng, A. C., Ghasemzadeh, N., Pernetz, M. A., Clements, S. D., & Williams, B. R. (2015) · International journal of cardiac imaging · doi:10.1007/s10554-015-0590-5 · Cited by 57
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
Wilke, I., Witzel, K., Münch, J., Pecha, S., Blankenberg, S., Reichenspurner, H. C., Willems, S., Patten, M., & Aydın, A. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12982 · Cited by 54
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice
Elliot, P. M., & Spirito, P. (2008) · Heart · doi:10.1136/hrt.2008.154385 · Cited by 52
Kamp, N., Chery, G. S., Kosinski, A. S., Desai, M. Y., Wazni, O. M., Sanders, G. D., Patel, M. R., Lópes, R. D., Morin, D. P., & Al‐Khatib, S. M. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.11.001 · Cited by 48
Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies
Marian, A. J., Asatryan, B., & Wehrens, X. H. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa116 · Cited by 49
2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
Габрусенко, С. А., Gudkova, A. Y., Koziolova, N. A., Alexandrova, S. А., Berseneva, M., Гордеев, М. Л., Sl, D., Zaklyazminskaya, E. V., Irtyuga, O. B., Kaplunova, V. Y., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4541 · Cited by 56
Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9147-0 · Cited by 46
Self-citationPrognostic significance of ambulatory ECG monitoring for ventricular arrhythmias
Katritsis, D. G., Siontis, G. C. M., & Camm, A. J. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.07.005 · Cited by 44
Cheng, Y., Wan, X., McElfresh, T. A., Chen, X., Gresham, K. S., ROSENBAUM, D. S., Chandler, M. P., & Stelzer, J. E. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00929.2012 · Cited by 43
Garratt, C. J., Elliot, P. M., Behr, E. R., Camm, A. J., Cowan, C., Cruickshank, S., Grace, A. A., GRIFFITH, M. J., Jolly, A., Lambiase, P. D., et al. (2010) · EP Europace · doi:10.1093/europace/euq261 · Cited by 43
Management of Hypertrophic Cardiomyopathy
Enriquez, A. D., & Goldman, M. E. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2013.12.004 · Cited by 42
Jackson, B. L., Lehmkuhl, L. B., & Adin, D. B. (2014) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2014.10.001 · Cited by 40
FITZGERALD, P. J., & Kusumoto, F. M. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0433-0 · Cited by 39
Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Adabağ, S., & Maron, B. J. (2007) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2007.00157.x · Cited by 40
Self-citationCorreia, E., Rodrigues, B., dos Santos, L. F., Moreira, D., Gama, P., Cabral, C., & Santos, O. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01427.x · Cited by 38
FRANCIA, P., SANTINI, D., MUSUMECI, B., SEMPRINI, L., ADDUCI, C., PAGANNONE, E., PROIETTI, G., VOLPE, M., & AUTORE, C. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12492 · Cited by 34
Translational investigation of electrophysiology in hypertrophic cardiomyopathy
Flenner, F., Jungen, C., Küpker, N., Ibel, A., Kruse, M., Koivumäki, J. T., Rinas, A., Zech, A. T. L., Rhoden, A., Wijnker, P. J. M., et al. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.009 · Cited by 34
Weissler‐Snir, A., Chan, R. H. M., Adler, A., Care, M. E., Chauhan, V. S., Gollob, M. H., Ziv‐Baran, T., Fourey, D., Hindieh, W., Rakowski, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.043 · Cited by 34
Spinner, J. A., Noel, C. V., Denfield, S. W., Krishnamurthy, R., Jeewa, A., Dreyer, W. J., & Maskatia, S. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.01.032 · Cited by 30
Nonsustained ventricular tachycardia in heart failure with preserved ejection fraction
Gutiérrez, A., Ash, J., Akdemir, B., Alexy, T., Cogswell, R. J., Chen, J., & Adabağ, S. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14043 · Cited by 30
Sudden Cardiac Death and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Moore, B. M., Semsarian, C., Chan, K. H., & Sy, R. W. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.07.019 · Cited by 29
Weissler‐Snir, A., Hindieh, W., SPEARS, D. A., Adler, A., Rakowski, H., & Chan, R. H. M. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13855 · Cited by 29
Cardiomiopatia Hipertrófica – Revisão
Bazan, S. G. Z., de Oliveira, G. O., da Silveira, C. F. D. S. M. P., Reis, F. M., Malagutte, K. N. D. S., Tinasi, L. S. N., Bazán, R., Hueb, J. C., & Okoshi, K. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190802 · Cited by 31
Jackson, B. L., Adin, D. B., & Lehmkuhl, L. B. (2015) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2015.03.002 · Cited by 27
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.11.026 · Cited by 35
Lerma, C., Wessel, N., Schirdewan, A., Kurths, J., & Glass, L. (2008) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-008-0326-y · Cited by 27
Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients
El-Saiedi, S. A., Seliem, Z. S., & Esmail, R. (2013) · Cardiology in the Young · doi:10.1017/s1047951113001030 · Cited by 27
Desfibrilador automático en la miocardiopatía hipertrófica. Experiencia de 3 centros
Marín, F. R., Gimeno, J. R., Payá, E., Garcı́a-Alberola, A., Pérez‐Álvarez, L., Fernández, X., de la Morena, G., Sogorb, F., Castro‐Beiras, A., Valdés, M., et al. (2006) · Revista Española de Cardiología · doi:10.1157/13089740 · Cited by 27
Bartoszuk, U., Keene, B. W., Toaldo, M. B., Pereira, N., Summerfield, N., Matos, J. N., & Glaus, T. M. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.11.005 · Cited by 26
Prajapati, C., Ojala, M., & Aalto‐Setälä, K. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032896 · Cited by 26
Atrial and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Kumar, K. R., Mandleywala, S. N., & Link, M. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.002 · Cited by 26
Hen, Y., Iguchi, N., Machida, H., Takada, K., Utanohara, Y., & Sumiyoshi, T. (2012) · Heart and Vessels · doi:10.1007/s00380-012-0300-3 · Cited by 24
Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy
Miller, M. A., Gomes, J. A., & Fuster, V. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1057 · Cited by 24
Sudden cardiac death: A comparative review of humans, dogs and cats
Brugada-Terradellas, C., Hellemans, A., Brugada, P., & Smets, P. M. Y. (2021) · The Veterinary Journal · doi:10.1016/j.tvjl.2021.105696 · Cited by 23
Tesic, M. B., Beleslin, B., Giga, V. L., Jovanović, I., Marinković, J., Trifunović, D., Petrović, O., Dobric, M. R., Aleksandric, S. B., Juričić, S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.021936 · Cited by 24
Myocardial Blood Flow and Fibrosis in Hypertrophic Cardiomyopathy
Aquaro, G. D., Todiere, G., Barison, A., Strata, E., Marzilli, M., Pingitore, A., & Lombardi, M. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.01.006 · Cited by 21
Comparison of 2 ambulatory patch ECG monitors: The benefit of the P-wave and signal clarity
Rho, R. W., Vossler, M. R., Blancher, S., & Poole, J. E. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.022 · Cited by 21
Morita, K., Utsunomiya, D., Oda, S., Komi, M., Namimoto, T., Hirai, T., Hashida, M., Takashio, S., Yamamuro, M., & Yamashita, Y. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.01.014 · Cited by 21
Implantable Cardioverter Defibrillator and Hypertrophic Cardiomyopathy. Experience at Three Centers
Marín, F. R., Gimeno, J. R., Payá, E., Garcı́a-Alberola, A., Pérez‐Álvarez, L., Fernández, X., de la Morena, G., Sogorb, F., Castro‐Beiras, A., Valdés, M., et al. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60004-8 · Cited by 20
Sudden cardiac death risk in hypertrophic cardiomyopathy
Ommen, S. R., & Gersh, B. J. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp307 · Cited by 20
Metadata
- Authors
- Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J.
- Affiliations
- Minneapolis Heart Institute Foundation (US)
- Minneapolis VA Medical Center (US)
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 45
- Issue
- 5
- Pages
- 697-704
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2134380184
- Cited by
- 273
- References
- 38
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 12 · 2023: 6 · 2022: 6 · 2021: 20 · 2020: 26 · 2019: 8 · 2018: 24 · 2017: 19 · 2016: 11 · 2015: 15 · 2014: 20 · 2013: 11 · 2012: 12
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- hypertrophic cardiomyopathy, ventricular arrhythmias, premature ventricular contractions, non-sustained ventricular tachycardia, supraventricular tachycardia, sudden death, prognostic factors, Holter monitoring, left ventricular hypertrophy, outflow obstruction, bradycardia
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bradycardia, Cardiomyopathy, Hypertrophic, Child, Child, Preschool, Female, Follow-Up Studies, Hospitals, Community, Humans, Male, Middle Aged, Minnesota, Risk Factors, Tachycardia, Supraventricular, Electrocardiography, Ambulatory, Comorbidity, Survival Analysis, Cardiology Service, Hospital, Death, Sudden, Cardiac, Tachycardia, Ventricular, Ventricular Premature Complexes, Atrial Premature Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
